May is Brain Tumor Awareness Month! Share your voice and raise brain tumor awareness: Download our free toolkit and spread the word.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
